umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Investigation of residuals responsible for binding of triazolo-pyrimidine inhibitors with HBsAg based on molecular docking and pharmacophore methods for designing potent HBsAg inhibitors
Umeå University, Faculty of Science and Technology, Department of Chemistry.
2015 (English)In: Journal of Hepatology, ISSN 0168-8278, E-ISSN 1600-0641, Vol. 62, p. S570-S570Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Elsevier, 2015. Vol. 62, p. S570-S570
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:umu:diva-111162DOI: 10.1016/S0168-8278(15)30868-0ISI: 000362830600381OAI: oai:DiVA.org:umu-111162DiVA, id: diva2:868606
Conference
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Vienna, April 22-26 2015
Note

Supplement: 2

Meeting Abstract: P0664

Available from: 2015-11-11 Created: 2015-11-06 Last updated: 2018-03-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text
By organisation
Department of Chemistry
In the same journal
Journal of Hepatology
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 42 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf